Pharmacotherapy patterns in patients with chronic idiopathic constipation beginning treatment with linaclotide or lubiprostone in the United States
Background: Chronic idiopathic constipation (CIC) is a common gastrointestinal disorder in community settings. Limited information exists on its treatment with the prosecretory agents linaclotide and lubiprostone. This retrospective cohort study investigated real-world pharmacotherapy patterns of li...
Saved in:
Main Authors: | Arpita Nag (Author), Rebecca Bornheimer (Author), Gerry Oster (Author) |
---|---|
Format: | Book |
Published: |
BioExcel Publishing Ltd,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lubiprostone: evaluation of the newest medication for the treatment of adult women with constipation-predominant irritable bowel syndrome
by: Tisha N Lunsford, et al.
Published: (2010) -
Negative chronotropic and inotropic effects of lubiprostone on iPS cell-derived cardiomyocytes via activation of CFTR
by: Hiraku Akita, et al.
Published: (2020) -
Patterns for Beginning Programmers
by: Bernstein, David
Published: (2022) -
Lubiprostone Improves Distal Segment-Specific Colonic Contractions through TRPC4 Activation Stimulated by EP3 Prostanoid Receptor
by: Byeongseok Jeong, et al.
Published: (2024) -
The ClC-2 Chloride Channel Activator, Lubiprostone, Improves Intestinal Barrier Function in Biopsies from Crohn's Disease but Not Ulcerative Colitis Patients
by: Young Su Park, et al.
Published: (2023)